Anavex Life Sciences Corp (AVXL)

[Steady_T]

Under the partnership, Anavex and Partex intend to co-develop a disease-focused Patient App ecosystem.
The first feature will be to inform patients and caregivers on preventive and curative options available in clinics and on the market.

Notice " inform patients and caregivers on preventive and curative options".

This is a step towards 2-73 or 3-71 as a preventative drug. Something that has been talked about before.

We just ran your genome and you are genetically prone to x,y,z diseases. We have 2-73 which has been shown to slow or prevent the development of x,y,z diseases.

That makes the "Healthcare Sales Marketing" part of the PR make a lot more sense.

Just some thoughts on the PR and possible implications.